Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

There is no experimental data available on skin sensitisation for the substance dipraseodymium dizirconium heptaoxide. However, using a weight of evidence approach including experimental data available for its constituents praseodymium(III,IV) oxide and zirconium dioxide (in the latter case, a zirconium dioxide test item was used in which a small amount of yttrium oxide was incorporated in the crystal lattice), it can be concluded that the substance is not expected to be a skin sensitiser.

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

1. Information on praseodymium(III,IV) oxide

In a study (Henzell, 2012; Klimisch 1) conducted to test the skin sensitisation properties of praseodymium(III,IV) oxide following OECD guideline 429 (LLNA), the results for all concentrations of the test material were negative. The positive control material yielded the expected result. Therefore, praseodymium(III,IV) oxide was considered to be a non-sensitiser under the conditions of this study in accordance with the CLP criteria.

2. Information on zirconium dioxide

Since no skin reaction was acknowledged in the elicited region of either the test agent group or the control group in the OECD 406 study (GPMT) performed by the Japanese Chemical Inspection and Testing Institute (1999; Klimisch 2 (non-GLP)), it was concluded that the test substance yttrium zirconium oxide (i.e. zirconium dioxide with a small amount of yttrium oxide incorporated into its crystal lattice) does not have any skin sensitising potential under the conditions of this test. On the other hand, it was confirmed that 2,4-dinitrochlorobenzene, the positive control agent, has an extreme skin sensitising potential. Since the result for the yttrium zirconium oxide test item was negative, it can be concluded that zirconium dioxide is also not a sensitiser.

3. Conclusion for the substance dipraseodymium dizirconium heptaoxide

Based on the negative results obtained for praseodymium(III,IV) oxide and zirconium dioxide (with a small amount of yttrium oxide incorporated into its crystal lattice) in skin sensitisation studies, it is safe to conclude that the substance dipraseodymium dizirconium heptaoxide does not need to be classified for skin sensitisation either.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

The substance does not need to be classified as skin sensitiser. This conclusion is based on the negative results of experiments performed with praseodymium(III,IV) oxide and zirconium dioxide (with a small amount of yttrium oxide incorporated into its crystal lattice).

No information is available on respiratory sensitisation.